Molecular Formula: C46H56N12O6
Molecular Weight: 873.032 g/mol
PubChem: CID 9919153
CAS Number: 87616-84-0
What is GHRP-6 Peptide?
GHRP-6 acts as a powerful stimulant which helps in the release of natural growth hormone (GH) from the anterior pituitary gland. In addition, it also acts as a ghrelin/growth hormone receptor agonist and is amongst the ghrelin analogues developed in recent decades. It has demonstrated a positive influence on cardiac muscle cells, scar formation, memory formation, sex motivation, and the neurons associated with Parkinson’s disease. The peptide is orally and sublingually active and moderately to highly specific in its action.
1. GHRP-6 Improves Memory
Scientists have been investigating the role of physical activity in learning and memory formation. It has been observed that physical activity such as exercise helps to enhance cognitive learning, particularly when it is done immediately following a learning activity. However, the precise mechanism remains hitherto unknown.
Initially, exercise was opined to help in cognition through improved blood circulation in the brain and increased production of growth hormone. Studies conducted on rodent models have highlighted how GHRP-6 helps to consolidate newly created memories and transform short-term memories into long-term storage. Significant scientific observations further prove the role of ghrelin/GHRP-6 in spatial learning tasks. Growth hormone secretagogues such as ghrelin, therefore bring about exercise-induced cognitive improvements. Hence, the role of GH may be possibly indirect and perhaps secondary to these peptides.
2. Protects Brain Tissue
The role of GHRP-6 in amelioration of stroke has been studied using appropriate animal models. The timely administration of the peptide not only protects brain tissue from reduced blood supply (following a stroke) but also helps in recovery from memory lapses due to stroke. At a molecular level, the peptide and its analogues prevent apoptosis of neurons of the central nervous system thereby preventing genetic reprogramming and inflammation.
3. Protects Parkinson’s Neurons
A study conducted in 2018 highlighted the prevalence of ghrelin receptors in substantia nigra, a part of the brain which is known to get affected in Parkinson’s disease. Patients who were genetically predisposed to the disease also showed significant reduction in ghrelin receptors in their substantia nigra. It was observed that genetically modulated rats also exhibit Parkinson’s symptoms when an antagonist is administered. Therefore, agonists like GHRP-6 may prove to be beneficial in the treatment of Parkinson’s diseases. Scientists hypothesize that the peptide associates with receptors present in the substantia nigra, decreases neuronal apoptosis and thus subsides or ameliorates the onset of this disease.
4. GHRP-6 Peptide Reduces Cardiac Problems
GHRP-6 was found to inhibit free radical-mediated cytotoxicity of cardiac cells in porcine models. Thus it can be used in development of drugs that will help to protect the viable cardiac tissues from damage after cardiac arrest. Such a medication would be helpful not only to reduce the chances of death but also to overcome any long-term adverse effects caused by cardiac arrest.
5. Alters Sex Motivation and Mood
Studies on male rats have highlighted the role of ghrelin receptors present in the central nervous system in modulating sexual behavior and motivation. Increased amounts of ghrelin have shown the ability to stimulate sexual impulses. GHRP-6 and its modified counterpart (which can antagonize the ghrelin receptor) have proven that ghrelin receptors located in specific areas of the brain influence sexual and reward-seeking conduct. The above findings can be extrapolated to hunger and other sorts of stimulation beyond sex and are applicable in conditions like hypoactive sexual desire.
There is also data to suggest that ghrelin can influence mood as part of its impact on motivation. The peptide and its analogues help to improve brain function associated with mood upliftment, stress relief as well as in overcoming depression in murine models. GHRP-6 can thus be used in treatment of stress, depression, anxiety and related mood disorders.
6. Improves Skin Appearance and Reduces Scaring
GHRP-6 promotes the survival of diverse kinds of cells by decreasing programmed cell death. The peptide also associates with the CD36 receptor and helps to promote blood vessel growth, particularly in wounds. GHRP-6 has proven to be effective in faster wound closure in rats. It helps in rapid wound healing, formation of extracellular matrix proteins such as collagen, promoting overall correct organization of tissue around a scar and thus reducing the appearance of scar marks.
Hypertrophic scars, like keloids, occur due to improper deposition of matrix proteins. GHRP-6 blocks this aberrant process of wound healing and is a boon for people who delay surgery to avoid such painful after-effects and aesthetic changes. GHRP-6 has demonstrated minimal to moderate side effects, low oral bioavailability and excellent subcutaneous bioavailability in murine models of study. The dosage (per kg) required in mice does not match up to that required for humans. GHRP-6 is sold by Biotech Peptides strictly for educational and scientific research purposes and not for human use.
Buy GHRP-6 peptide, only if you are a licensed researcher.